Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2005
Botulinum toxin a in the treatment of chromhidrosis.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu Jessie M, Mamelak Adam J, Nussbaum Rachel, McElgunn Patrick S J
Аннотация
BACKGROUND: Chromhidrosis is an uncommon disorder characterized by secretion of colored sweat by apocrine glands, typically localized to the face or axilla. The current treatments available for chromhidrosis are time consuming and frequently ineffective.
OBJECTIVE: Our purpose is to demonstrate a novel approach to the treatment of apocrine chromhidrosis.
METHODS: We report a case of apocrine chromhidrosis successfully treated with botulinum toxin A (BTX-A; Botox).
RESULTS: BTX-A therapy successfully controlled facial chromhidrosis, and the effects were visible at 19 weeks post-treatment. The therapeutic benefits may be attributed to its inhibitory effects on cholinergic stimulation, adrenergic stimulation, and substance P release, although further studies are necessary to elucidate the precise mechanism of action.
CONCLUSION: This report demonstrates a new therapeutic approach to patients suffering from chromhidrosis.
OBJECTIVE: Our purpose is to demonstrate a novel approach to the treatment of apocrine chromhidrosis.
METHODS: We report a case of apocrine chromhidrosis successfully treated with botulinum toxin A (BTX-A; Botox).
RESULTS: BTX-A therapy successfully controlled facial chromhidrosis, and the effects were visible at 19 weeks post-treatment. The therapeutic benefits may be attributed to its inhibitory effects on cholinergic stimulation, adrenergic stimulation, and substance P release, although further studies are necessary to elucidate the precise mechanism of action.
CONCLUSION: This report demonstrates a new therapeutic approach to patients suffering from chromhidrosis.